Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian CancerEllen L. Goode, Naveena Singh, Aleksandra Tołoczko et al.|JAMA Oncology|2017Cited by 409
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyAnna DeFazio, Martin Köbel, Jason Madore et al.|British Journal of Cancer|2014Cited by 113
Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer OutcomeBridget Charbonneau, Louise A. Brinton, Kirsten B. Moysich et al.|Cancer Immunology Research|2014Cited by 27
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer OutcomeKristin L. White, Ursula Eilber, Robert A. Vierkant et al.|Cancer Epidemiology Biomarkers & Prevention|2013Cited by 23
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J. Winham, Jonathan P. Tyrer, Ailith Pirie et al.|Cancer Epidemiology Biomarkers & Prevention|2016Cited by 15